Trumping Science: Part II

As Inauguration Day nears, scientists and science advocates are voicing their unease with the Trump Administration’s potential effects on research.

Written byBob Grant
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

WIKIMEDIA, MICHAEL VADONIn mid-November, pollster John Zogby sought to reassure nervous researchers. “The important thing is that you should not assume that you’re screwed,” he said at a Research!America briefing on the state of health, science, and research under Trump. “You must go on and understand that medical health care research is vital, and that folks do understand it, and that there probably are a million other places that can be cut.”

But since the November election that saw the real estate magnate and former reality TV star claim the presidency, scientists have been coming out in droves to voice their concern that the new administration could spell shrunken federal research budgets, reneged climate change accords, or worse. Many of the expressions of concern have been coming in the form of open letters. As of today (December 6) there are at least four such letters circulating online.

One open letter, from the Union of Concerned Scientists, bears the signatures of more than 2,300 researchers, including 22 Nobel Laureates. “From disease outbreaks to climate change to national security to technology innovation, people benefit when our nation’s policies are informed by science unfettered by inappropriate political or corporate influence,” ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies